Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphatidylinositol transfer protein, cytoplasmic 1 pseudogene (ENSG00000229747) is a non-functional genetic element in the human genome that resembles the active PITPNC1 gene. Unlike the functional protein, which plays roles in lipid signaling and membrane trafficking, the pseudogene does not produce a protein and has no established biological function, clinical relevance, or therapeutic application[4][2]. Most pseudogenes are considered genomic relics and are not targeted by drugs, used as biomarkers, or involved in disease pathways[4]. If you are interested in the functional gene "phosphatidylinositol transfer protein, cytoplasmic 1" (PITPNC1), that entity does have established roles in cell signaling, lipid transfer, and potentially in disease; instructions here are specifically for the pseudogene, which is not a therapeutic target[4][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylinositol transfer protein, cytoplasmic 1 pseudogene.